CureVac NV held its Annual General Meeting of Shareholders on June 24, 2025. During the meeting, several proposals were presented and approved. These included the adoption of the annual accounts for the financial year 2024, the release of managing directors from liability for the exercise of their duties during the financial year 2024, and the reappointment of Jean Stéphenne, Mehdi Shahidi, Debra Barker, and Klaus Schollmeier as members of the supervisory board. The meeting also approved the authorisation of the management board to issue shares and to grant rights to subscribe for shares, limit or exclude pre-emption rights, and the reappointment of the external auditor for the financial year 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CureVac NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-063026), on June 26, 2025, and is solely responsible for the information contained therein.